BAM Capital

Latest statistics and disclosures from BAM Capital's latest quarterly 13F-HR filing:

Portfolio Holdings for BAM Capital

BAM Capital holds 30 positions in its portfolio as reported in the September 2011 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf (SPY) 24.4 $24M +950% 210k 113.17
 View chart
Pharmasset 11.7 $11M +528% 138k 82.37
 View chart
iShares Russell 2000 Index (IWM) 9.2 $9.0M NEW 140k 64.25
 View chart
Biogen Idec (BIIB) 8.9 $8.7M +179% 93k 93.15
 View chart
Targacept 6.4 $6.2M +59% 413k 15.00
 View chart
Netflix (NFLX) 5.8 $5.7M NEW 50k 113.28
 View chart
Medivation 5.5 $5.3M NEW 313k 16.97
 View chart
Keryx Biopharmaceuticals 5.2 $5.0M +41% 1.7M 3.00
 View chart
Vivus 4.5 $4.4M -40% 542k 8.06
 View chart
Barclays Bk Plc ipth s^p vix 4.4 $4.3M NEW 80k 53.37
 View chart
Elan Corporation 2.5 $2.4M -58% 231k 10.53
 View chart
Research In Motion 2.1 $2.1M NEW 102k 20.31
 View chart
Delcath Sys 1.9 $1.8M NEW 551k 3.34
 View chart
Delcath Sys 1.8 $1.7M NEW 512k 3.34
 View chart
Acorda Therapeutics 1.2 $1.2M +79% 60k 20.00
 View chart
XenoPort 1.0 $941k +2% 161k 5.86
 View chart
United Therapeutics Corporation (UTHR) 0.8 $783k -96% 21k 37.45
 View chart
InterDigital (IDCC) 0.5 $521k NEW 11k 46.52
 View chart
Dendreon Corporation 0.4 $386k +83% 43k 9.00
 View chart
Eli Lilly & Co. (LLY) 0.3 $285k 7.7k 37.01
 View chart
Affymax (AFFY) 0.3 $268k NEW 60k 4.48
 View chart
NPS Pharmaceuticals 0.2 $235k NEW 36k 6.50
 View chart
INC Ventrus Biosciences 0.2 $236k NEW 26k 9.02
 View chart
Inhibitex 0.2 $198k NEW 80k 2.46
 View chart
ACADIA Pharmaceuticals (ACAD) 0.2 $164k NEW 152k 1.08
 View chart
shares Agenus 0.1 $129k NEW 274k 0.47
 View chart
Delcath Systems 0.1 $97k -97% 29k 3.36
 View chart
Genvec 0.1 $100k -9% 35k 2.86
 View chart
BioSante Pharmaceuticals 0.1 $68k NEW 30k 2.27
 View chart
GTx 0.1 $52k +24% 15k 3.37
 View chart

Past Filings by BAM Capital

SEC 13F filings are viewable for BAM Capital going back to 2010